Lalitha Kodandapani

Title: Lalitha Kodandapani: Innovator in Therapeutic Protein Development

Introduction

Lalitha Kodandapani is a prominent inventor based in San Diego, California. She has made significant contributions to the field of therapeutic proteins, focusing on methods that enhance their efficacy while minimizing adverse side effects. Her innovative approach has the potential to revolutionize the way therapeutic proteins are developed and utilized in medical treatments.

Latest Patents

Lalitha holds a patent for "Methods for assessing and identifying or evolving conditionally active therapeutic proteins." This patent outlines methods for evolving, selecting, or producing therapeutic proteins that exhibit reduced adverse side effects. The patent describes an in vitro assay designed to identify conditionally active therapeutic proteins that demonstrate improved activity in specific in vivo environments. The methodology includes testing the activity of a protein under conditions where normal or increased activity is desired, as well as under conditions where reduced activity is preferred. By comparing these activities, Lalitha's methods allow for the selection of proteins that are conditionally active, thereby enhancing their therapeutic potential.

Career Highlights

Lalitha is currently employed at Halozyme, Inc., where she continues to advance her research in therapeutic proteins. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.

Collaborations

Lalitha collaborates with esteemed colleagues, including Louis Howard Bookbinder and Gregory Ian Frost. These partnerships enhance her research efforts and contribute to the development of groundbreaking therapeutic solutions.

Conclusion

Lalitha Kodandapani is a trailblazer in the field of therapeutic protein development, with a focus on creating conditionally active proteins that improve patient outcomes. Her innovative methods and dedication to research position her as a key figure in biotechnology.